MRNA phase III melanoma success supports broader cancer expansion
The company cites positive phase III melanoma data and says manufacturing is at commercial scale, enabling global trials across lung, bladder and renal cancers.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.